Skip to main content

Arax Advisory Partners

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1586767 DENVER, CO

Position in REGN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$473,628
-$288,979 QoQ
Shares Held
613
-38.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Arax Advisory Partners holds $6,272,368 across 181 Biotechnology names. REGN ranks #5 (7.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 REGN
Regeneron Pharmaceuticals, Inc.
This page
613 $473,628

All Filings in REGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $473,628 613
2025-12-31 $762,607 988
2025-09-30 $5,308,953 9,442
2025-06-30 $42,525 81
2025-03-31 $39,321 62
2024-12-31 $9,972 14
2024-09-30 $44,151 42
2024-06-30 $44,143 42
2024-03-31 $13,474 14
2023-12-31 $12,295 14
2023-09-30 $12,343 15
2023-06-30 $10,059 14
2023-03-31 $12,325 15
2022-12-31 $7,936 11
2022-09-30 $6,888 10
2022-06-30 $2,364 4
2022-03-31 $1,396 2
2021-12-31 $2,526 4
2021-09-30 $1,210 2